← Leaderboards
Ralph B D'agostino
Tufts Medical Center
$5,148,585
Attributed
$6,874,876
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$6,874,876 · 2
By mechanism
R01$3,452,583 · 1
U01$3,422,293 · 1
Top collaborators
- Virginia Athena Triant4 shared
Most similar at Tufts Medical Center
Same institution · by research overlap
- Inga Peter$17,466,985
- Ernst John Schaefer$8,539,085
- Joachim H Ix$16,690,262
- Michael E Mendelsohn$8,988,947
- James E Udelson$1,950,660
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchCohortCardiovascular SystemAmericanAmerican Heart AssociationAgingBaseAlgorithmsCardiologyCardiovascular DiseasesCardiovascular Disorder PreventionCardiovascular Disorder RiskAtherosclerosisCardiovascular Risk FactorAdvocacyCaringCategoriesCholesterolChronicClinical ApplicationClinical CareClinically RelevantAdjudicateCollege
Grant awards (7)
Optimizing Cardiovascular Risk Prediction in HIV$852,205
R01 · FY2020 · HL
Optimizing Cardiovascular Risk Prediction in HIV$851,435
R01 · FY2019 · HL
Optimizing Cardiovascular Risk Prediction in HIV$855,247
R01 · FY2018 · HL
Optimizing Cardiovascular Risk Prediction in HIV$893,696
R01 · FY2017 · HL
Data Coordinating Center for IMMEDIATE Trial$1,466,610
U01 · FY2006 · HL · contact PI
Data Coordinating Center for IMMEDIATE Trial$1,251,007
U01 · FY2005 · HL
Data Coordinating Center for IMMEDIATE Trial$704,676
U01 · FY2004 · HL